David F Blackburn

Summary

Affiliation: University of Saskatchewan
Country: Canada

Publications

  1. ncbi Proposing a redefinition of pharmaceutical care
    David F Blackburn
    Patient Adherence, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada
    Ann Pharmacother 46:447-9. 2012
  2. ncbi Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada
    Can J Cardiol 21:485-8. 2005
  3. ncbi Cardiovascular morbidity associated with nonadherence to statin therapy
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    Pharmacotherapy 25:1035-43. 2005
  4. ncbi Antihypertensive medications and blood sugar: theories and implications
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon
    Can J Cardiol 22:229-33. 2006
  5. ncbi Coding of heart failure diagnoses in Saskatchewan: a validation study of hospital discharge abstracts
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Canada
    J Popul Ther Clin Pharmacol 18:e407-15. 2011
  6. ncbi Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    J Hypertens 25:1499-505. 2007
  7. ncbi Increased use of acid-suppressing drugs before the occurrence of ischemic events: a potential source of confounding in recent observational studies
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    Pharmacotherapy 30:985-93. 2010
  8. ncbi Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003
    Darcy A Lamb
    College of Pharmacy and Nutrition and the College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    Circ Cardiovasc Qual Outcomes 2:228-35. 2009
  9. ncbi Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada
    Charity D Evans
    University of Saskatchewan, College of Pharmacy and Nutrition, 110 Science Place, Saskatoon, Saskatchewan S7N 5C9, Canada
    J Manag Care Pharm 15:476-84. 2009
  10. ncbi A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study
    Charity D Evans
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada
    Trials 11:76. 2010

Collaborators

Detail Information

Publications13

  1. ncbi Proposing a redefinition of pharmaceutical care
    David F Blackburn
    Patient Adherence, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada
    Ann Pharmacother 46:447-9. 2012
    ..Consequently, the current definition of pharmaceutical care and its associated care processes need to be modified to ensure the activities of pharmacists are being focused on high-priority patients on a consistent basis...
  2. ncbi Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada
    Can J Cardiol 21:485-8. 2005
    ..Population studies of statin adherence are generally restricted to one to two years of follow-up and do not analyze adherence to other drugs...
  3. ncbi Cardiovascular morbidity associated with nonadherence to statin therapy
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    Pharmacotherapy 25:1035-43. 2005
    ..To measure the extent of cardiovascular morbidity associated with nonadherence to 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy...
  4. ncbi Antihypertensive medications and blood sugar: theories and implications
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon
    Can J Cardiol 22:229-33. 2006
    ..The number one priority should be controlling blood pressure in a timely manner...
  5. ncbi Coding of heart failure diagnoses in Saskatchewan: a validation study of hospital discharge abstracts
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Canada
    J Popul Ther Clin Pharmacol 18:e407-15. 2011
    ..Validity of Heart Failure (HF) diagnoses from administrative records has not been extensively evaluated, especially with respect to small / unselected hospitals...
  6. ncbi Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    J Hypertens 25:1499-505. 2007
    ..The role of atenolol in the management of patients with hypertension is currently under scrutiny. Our aim was to evaluate the real-world consequences of recent clinical trial findings...
  7. ncbi Increased use of acid-suppressing drugs before the occurrence of ischemic events: a potential source of confounding in recent observational studies
    David F Blackburn
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    Pharmacotherapy 30:985-93. 2010
    ..To determine if the use of acid-suppressing drugs is increased before the occurrence of ischemic events...
  8. ncbi Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003
    Darcy A Lamb
    College of Pharmacy and Nutrition and the College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    Circ Cardiovasc Qual Outcomes 2:228-35. 2009
    ..The use of evidence-based medications in patients with heart failure has increased over the past 10 years. We aimed to determine whether adherence to these medications has also increased during this time...
  9. ncbi Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada
    Charity D Evans
    University of Saskatchewan, College of Pharmacy and Nutrition, 110 Science Place, Saskatoon, Saskatchewan S7N 5C9, Canada
    J Manag Care Pharm 15:476-84. 2009
    ..It is unknown if an association exists between the type of community pharmacy and the degree of medication adherence exhibited by patrons-patients...
  10. ncbi A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study
    Charity D Evans
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada
    Trials 11:76. 2010
    ..This novel design integrates cluster randomization and an outcome evaluation of medication adherence using a population-based administrative data source in the province of Saskatchewan, Canada...
  11. ncbi The Collaborative Cardiovascular Risk Reduction in Primary Care (CCARP) study
    Charity D Evans
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    Pharmacotherapy 30:766-75. 2010
    ....
  12. ncbi Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion
    Carolyn D Bubbar
    College of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Ann Pharmacother 41:129-32. 2007
    ..Therefore, ACE inhibitors should be discouraged for the majority of patients with primary aldosteronism, even in the face of renal or cardiac disease...
  13. ncbi Issues in reporting epidemiological studies: no data are given to support generalisation
    David F Blackburn
    BMJ 330:146; author reply 146-7. 2005